Glucagon for Severe Low Blood Sugar: Gvoke, Baqsimi, Zegalogue and Kits
Glucagon is a hormone that raises blood glucose, and it is the treatment for a severe low when a person cannot safely take sugar by mouth. The ADA recommends it be prescribed for everyone taking insulin or at high risk of lows. This page lists the FDA-approved forms. It gives no doses: use yours exactly as prescribed.
What glucagon does
Your pancreas makes glucagon to tell the liver to release stored glucose. As a medicine, it does the same thing quickly. The NIDDK calls it the best way to treat severely low blood glucose and says family and friends should be taught when and how to give it. The ADA lists a severe low, level 3, as an event needing another person’s help, and says glucagon is indicated for people who cannot or will not take carbohydrate by mouth. People giving it do not have to be health professionals. The ADA prefers ready-to-use forms that need no mixing, and intranasal and ready-to-inject forms for faster correction.
FDA-approved forms
Facts below are from each product’s FDA-approved label on DailyMed or Drugs@FDA. There may be other brands of kit and generics.
| Product | Form | Route | Who the label covers | Label |
|---|---|---|---|---|
| Gvoke | Ready-to-use solution: HypoPen auto-injector, prefilled syringe, and a vial-and-syringe kit | Injection under the skin | Ages 2 and older with diabetes | GVOKE label (Xeris), Oct 2026 |
| Zegalogue (dasiglucagon) | Ready-to-use autoinjector and prefilled syringe | Injection under the skin | Adults and children who weigh at least 20 kg | ZEGALOGUE label (Novo Nordisk), rev. 06/2026 |
| Baqsimi | Nasal powder in a one-use device | Into the nose | Ages 1 and older with diabetes | BAQSIMI label (Amphastar), rev. Mar 2025 |
| Glucagon Emergency Kit | Vial of powder plus a syringe of liquid that must be mixed | Injection | Children and adults with diabetes | Kit label (Amphastar), Aug 2026 |
Label contents change; check the current label and your pharmacy’s product. Some glucagon products are also approved as a diagnostic aid for imaging, which is a different use.
Things the labels say
- Who should not use it. The labels list a tumor of the adrenal gland (pheochromocytoma) as a reason not to use glucagon, and Zegalogue’s also lists insulinoma. Tell your prescriber about your health history.
- It may not work if the liver has little stored glucose, for example with starvation, adrenal insufficiency or chronic low glucose, according to the Gvoke and Zegalogue labels. The person may then need glucose by other means, which is why 911 is called.
- Allergic reactions are possible. The Gvoke label lists rash, and in some cases anaphylaxis, among reported reactions.
- It comes in single-use devices. Each product has its own instructions for use. Learn yours before you need it.
Being prepared
- Ask your care team whether glucagon is right for you. The ADA says it should be prescribed for everyone on insulin or at high risk.
- Teach the people around you where it is kept and how to use it, as the ADA recommends for family, caregivers and school staff.
- Check the expiry date and storage on the label, and replace when needed.
- Practice with the maker’s trainer or video if there is one; ask your pharmacist.
- Tell your care team after any severe low. They will want to review your plan.
Glucagon is for severe lows only. For mild and moderate lows, use the rule of 15 with glucose tablets or other quick carbohydrate. Know the signs on the low blood sugar symptoms page.
Frequently asked questions
What is glucagon?
A hormone that raises blood glucose. The NIDDK calls it the best way to treat severely low blood glucose. As a medicine, it comes as an injection or a nasal powder and is prescribed for people at risk of severe lows.
Who should have glucagon?
The ADA recommends that glucagon be prescribed for all people taking insulin or at high risk for hypoglycemia, and that family, caregivers, school staff and others know where it is kept and how to give it. Ask your care team whether you should have it.
What are the FDA-approved forms?
Ready-to-use injectables (Gvoke, Zegalogue), a nasal powder (Baqsimi), and glucagon emergency kits that are mixed before injecting. The table lists each, its age or weight limit and its route from the FDA labels.
What do I do after giving glucagon?
The NIDDK says to call 911 right away after giving glucagon, or if you do not have a kit with you. Follow the maker’s instructions for use that came with your product.
How much do I give?
This site does not give dosing. Use the product exactly as prescribed and as the maker’s instructions for use say. Ask your pharmacist or care team to show you, and keep the instructions with the kit.
Information only, not medical advice. Your care team may set different targets for you, and only a lab test ordered by a clinician can diagnose diabetes or prediabetes. See our medical disclaimer.
Sources
- NIDDK: Low Blood Glucose (Hypoglycemia)
- ADA Standards of Care in Diabetes—2026, Section 6: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises
- GVOKE (glucagon) injection, FDA label via DailyMed (Xeris), October 2026
- ZEGALOGUE (dasiglucagon) injection, FDA label revised 06/2026
- BAQSIMI (glucagon) nasal powder, FDA label via DailyMed (Amphastar), revised March 2025
- Glucagon Emergency Kit for Low Blood Sugar, FDA label via DailyMed (Amphastar), August 2026
Last reviewed: by the Diabetes Blogs editorial team. Information only, not medical advice.
